Moriwaki T - Search Results

1

Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS).

Chida K, Kotani D, Moriwaki T, Fukuoka S, Masuishi T, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Komoda M, Makiyama A, Denda T, Hatachi Y, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Ando K, Yuki S, Okita Y, Kusaba H, Sakai D, Okamoto K, Tamura T, Yamashita K, Gosho M, Shimada Y. Chida K, et al. Among authors: moriwaki t. Front Oncol. 2021 Mar 8;11:576036. doi: 10.3389/fonc.2021.576036. eCollection 2021. Front Oncol. 2021. PMID: 33763345 Free PMC article.

2

[Clinical study of TS-1 therapy for inoperable and recurrent gastric cancer].

Moriwaki T, Hyodo I, Nishina T, Kajiwara T, Tsuzuki T, Hirao K, Nakauchi M, Nasu J, Hirasaki S, Endo H, Masumoto T, Tanimizu M, Kubo Y, Kurita A. Moriwaki T, et al. Gan To Kagaku Ryoho. 2003 Apr;30(4):489-94. Gan To Kagaku Ryoho. 2003. PMID: 12722679 Japanese.

3

[Clinical study of irinotecan therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer].

Nishina T, Hyodo I, Moriwaki T, Kajiwara T, Tsuzuki T, Hirao K, Tubouchi E, Nasu J, Hirasaki S, Masumoto T, Kubo Y, Kurita A. Nishina T, et al. Among authors: moriwaki t. Gan To Kagaku Ryoho. 2004 Sep;31(9):1361-4. Gan To Kagaku Ryoho. 2004. PMID: 15446557 Japanese.

4

[Clinical study of gemcitabine therapy for recurrent or metastatic pancreatic cancer].

Moriwaki T, Hyodo I, Nishina T, Nasu J, Hidaka S, Kajiwara T, Tsuzuki T, Hirao K, Tsubouchi E, Yamauchi Y, Hirasaki S, Masumoto T, Tanada M. Moriwaki T, et al. Gan To Kagaku Ryoho. 2004 Sep;31(9):1373-6. Gan To Kagaku Ryoho. 2004. PMID: 15446559 Japanese.

5

A phase I study of doxifluridine combined with weekly paclitaxel for metastatic gastric cancer.

Moriwaki T, Hyodo I, Nishina T, Hirao K, Tsuzuki T, Hidaka S, Kajiwara T, Endo S, Nasu J, Hirasaki S, Masumoto T, Kurita A. Moriwaki T, et al. Cancer Chemother Pharmacol. 2005 Aug;56(2):138-44. doi: 10.1007/s00280-004-0983-y. Epub 2005 Apr 13. Cancer Chemother Pharmacol. 2005. PMID: 15827767 Clinical Trial.

6

[A case of Cronkhite-Canada syndrome associated with cholangiocellular carcinoma].

Hirasaki S, Tanimizu M, Moriwaki T, Kajiwara T, Nishina T, Hyodo I. Hirasaki S, et al. Among authors: moriwaki t. Nihon Shokakibyo Gakkai Zasshi. 2005 May;102(5):583-8. Nihon Shokakibyo Gakkai Zasshi. 2005. PMID: 15920956 Review. Japanese. No abstract available.

7

[Clinical study of irinotecan plus infusional fluorouracil/l-leucovorin (FOLFIRI) in patients with fluoropyrimidine-resistant metastatic colorectal cancer].

Moriwaki T, Hyodo I, Nishina T, Kajiwara T, Kataoka J, Hori S, Nasu J, Imamine S, Iguchi H. Moriwaki T, et al. Gan To Kagaku Ryoho. 2007 Dec;34(13):2249-53. Gan To Kagaku Ryoho. 2007. PMID: 18079624 Japanese.

8

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.

Matsubara J, Nishina T, Yamada Y, Moriwaki T, Shimoda T, Kajiwara T, Nakajima TE, Kato K, Hamaguchi T, Shimada Y, Okayama Y, Oka T, Shirao K. Matsubara J, et al. Among authors: moriwaki t. Br J Cancer. 2008 Feb 26;98(4):832-9. doi: 10.1038/sj.bjc.6604211. Epub 2008 Jan 29. Br J Cancer. 2008. PMID: 18231104 Free PMC article.

9

High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.

Kajiwara T, Nishina T, Hyodo I, Moriwaki T, Endo S, Nasu J, Hori S, Matsuura B, Hiasa Y, Onji M. Kajiwara T, et al. Among authors: moriwaki t. Oncology. 2009;76(5):342-9. doi: 10.1159/000209964. Epub 2009 Mar 23. Oncology. 2009. PMID: 19307741

10

Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study).

Moriwaki T, Bando H, Takashima A, Yamazaki K, Esaki T, Yamashita K, Fukunaga M, Miyake Y, Katsumata K, Kato S, Satoh T, Ozeki M, Baba E, Yoshida S, Boku N, Hyodo I. Moriwaki T, et al. Med Oncol. 2012 Dec;29(4):2842-8. doi: 10.1007/s12032-011-0151-2. Epub 2011 Dec 31. Med Oncol. 2012. PMID: 22209842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters